Details of the Drug

General Information of Drug (ID: DMEDF2B)

• Drug Name: Adcetris

Indication

Disease Entry	ICD 11	Status	REF
Cutaneous T-cell lymphoma	2B01	Phase 3	[1]
Hodgkin lymphoma	2B30	Phase 3	[2]
T-cell leukaemia	2A90	Phase 3	[1]
Diffuse large B-cell lymphoma	2A81	Phase 2	[1]
Non-hodgkin lymphoma	2B33.5	Phase 2	[2]

• Cross-matching ID:
  PubChem CID: 117723179
  TTD ID: D0F4IM
• Repurposed Drugs (RPD): Click to Jump to the Detailed RPD Information of This Drug

References

• [1] Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
• [2] Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)